An experienced scientist-turned-entrepreneur who has been involved in building startups for over 10 years. These startups have been primarily focused on oncology and cardiovascular disease innovations, specifically biomarkers to be developed for in vitro diagnostic applications. Egbert holds an MBA from Maastricht University Business School (2009) and a PhD in Molecular biology / biochemistry from the University of Amsterdam. For Egbert, the MLA Diagnostics project brings together his passion and interest in applied science in a domain where better solutions are sorely needed. Melanoma is a serious disease and patients have a right to receive improved treatment, which MLA Diagnostics will facilitate!